← Back to all trials
Completed
NCT06595030
Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Sex: All
Ages: 55 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 101
Sponsor: Icahn School of Medicine at Mount Sinai
Location: Icahn School of Medicine at Mount Sinai Menands New York
Summary
Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 participants who will experience either the active TLI or the placebo for 6 months.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score \
Source: ClinicalTrials.gov (NCT06595030). StuddyBuddy aggregates publicly available trial information.